OS Therapies (NYSE:OSTX) Receives “Buy” Rating from D. Boral Capital
D. Boral Capital reiterated their buy rating on shares of OS Therapies (NYSE:OSTX – Free Report) in a research note issued to investors on Monday morning,Benzinga reports. They currently have a $20.00 target price on the stock. Separately, Maxim Group increased their target price on shares of OS Therapies from $8.00 to $15.00 and gave […]
D. Boral Capital reiterated their buy rating on shares of OS Therapies (NYSE:OSTX – Free Report) in a research note issued to investors on Monday morning,Benzinga reports. They currently have a $20.00 target price on the stock. Separately, Maxim Group increased their target price on shares of OS Therapies from $8.00 to $15.00 and gave […]
